Glaukos Corporation (GKOS), headquartered in San Clemente, California, is a leader in ophthalmic medical technology, dedicated to advancing innovative treatments for glaucoma and other vision-threatening conditions. The company specializes in minimally invasive surgical techniques and cutting-edge drug delivery systems, greatly enhancing patient care and outcomes. With a strong commitment to research and development, Glaukos boasts a promising pipeline aimed at addressing the burgeoning global demand for effective ocular therapies, reinforcing its status as a pivotal player in the effort to combat blindness worldwide. Show more

Location: ONE GLAUKOS WAY, ALISO VIEJO, CA, UNITED STATES, 92656, Aliso Viejo, CA, 92656, USA | Website: https://www.glaukos.com | Industry: MEDICAL DEVICES | Sector: HEALTHCARE

Market Cap

6.857B

52 Wk Range

$73.16 - $161.78

Previous Close

$119.07

Open

$120.14

Volume

761,121

Day Range

$116.63 - $123.54

Enterprise Value

6.669B

Cash

98.25M

Avg Qtr Burn

-10.09M

Insider Ownership

3.30%

Institutional Own.

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Epioxa™ (Epi-on) Details Keratoconus	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
travoprost-iDose® TR (IMPLANT) Details Primary open angle glaucoma , Eye disease	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
iDose TREX Details Eye disease , Primary open angle glaucoma	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
iLution Travoprost (GLK-311) Details Eye disease , Primary open angle glaucoma	Phase 2a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.